The proteasome in Alzheimer's disease and Parkinson's disease: Lessons from ubiquitin B+1

Trends in Molecular Medicine

Volumn 11, Issue 11, 2005, Pages 488-495

  Hol, Elly M ^a   Van Leeuwen, Fred W ^a   Fischer, David F ^b,c  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c Galapagos Genomics   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEASOME; PROTEASOME INHIBITOR; PROTEIN SUBUNIT; UBIQUITIN;

ALZHEIMER DISEASE; DISEASE COURSE; GENE DELETION; HUMAN; IMMUNOREACTIVITY; NERVE DEGENERATION; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN MOTIF; REVIEW; UBIQUITINATION;

EID: 27844548672     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2005.09.001     Document Type: Article

References (69)

1. C.M. Pickart Back to the future with ubiquitin Cell 116 2004 181 190
2. A.L. Goldberg Protein degradation and protection against misfolded or damaged proteins Nature 426 2003 895 899
3. R.L. Welchman Ubiquitin and ubiquitin-like proteins as multifunctional signals Nat. Rev. Mol. Cell Biol. 6 2005 599 609
4. C.M. Pickart, and R.E. Cohen Proteasomes and their kin: proteases in the machine age Nat. Rev. Mol. Cell Biol. 5 2004 177 187
5. A. Ciechanover, and P. Brundin The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg Neuron 40 2003 427 446
6. W. Scheper, and E.M. Hol Protein quality control in Alzheimer's disease: a fatal saviour Curr Drug Targets CNS Neurol. Disord. 4 2005 283 292
7. F.M. de Vrij Protein quality control in Alzheimer's disease by the ubiquitin proteasome system Prog. Neurobiol. 74 2004 249 270
8. M.H. Glickman, and A. Ciechanover The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction Physiol. Rev. 82 2002 373 428
9. K. Watase, and H.Y. Zoghbi Modelling brain diseases in mice: the challenges of design and analysis Nat. Rev. Genet. 4 2003 296 307
10. C.J. Cummings Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice Neuron 24 1999 879 892
11. J.M. Warrick Ataxin-3 suppresses polyglutamine neurodegeneration in Drosophila by a ubiquitin-associated mechanism Mol. Cell 18 2005 37 48
12. M. Arrasate Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death Nature 431 2004 805 810
13. C.M. Pickart, and D. Fushman Polyubiquitin chains: polymeric protein signals Curr. Opin. Chem. Biol. 8 2004 610 616
14. C.A. Semple The comparative proteomics of ubiquitination in mouse Genome Res. 13 2003 1389 1394
15. E.W. Doss-Pepe Alpha-synuclein and parkin contribute to the assembly of ubiquitin lysine 63-linked multiubiquitin chains J. Biol. Chem. 280 2005 16619 16624
16. K.L. Lim Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation J. Neurosci. 25 2005 2002 2009
17. K.S. McNaught Failure of the ubiquitin-proteasome system in Parkinson's disease Nat. Rev. Neurosci. 2 2001 589 594
18. C.A. Ross, and C.M. Pickart The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases Trends Cell Biol. 14 2004 703 711
19. F.W. van Leeuwen Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients Science 279 1998 242 247
20. D.F. Fischer Disease-specific accumulation of mutant ubiquitin as a marker for proteasomal dysfunction in the brain FASEB J. 17 2003 2014 2024
21. J. Lotharius, and P. Brundin Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein Nat. Rev. Neurosci. 3 2002 932 942
22. K.S. McNaught Altered proteasomal function in sporadic Parkinson's disease Exp. Neurol. 179 2003 38 46
23. R. de Pril Accumulation of aberrant ubiquitin induces aggregate formation and cell death in polyglutamine diseases Hum. Mol. Genet. 13 2004 1803 1813
24. K. Lindsten Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation J. Cell Biol. 157 2002 417 427
25. F.M. de Vrij Mutant ubiquitin expressed in Alzheimer's disease causes neuronal death FASEB J. 15 2001 2680 2688
26. Y.A. Lam Inhibition of the ubiquitin-proteasome system in Alzheimer's disease Proc. Natl. Acad. Sci. U. S. A. 97 2000 9902 9906
27. A.D. Hope Alzheimer's associated variant ubiquitin causes inhibition of the 26S proteasome and chaperone expression J. Neurochem. 86 2003 394 404
28. van Leeuwen, F.W. et al. Frameshift proteins in autosomal dominant forms of Alzheimer's disease and other tauopathies. Neurology (in press)
29. P. Fratta Mutant ubiquitin UBB+1 is accumulated in sporadic inclusion-body myositis muscle fibers Neurology 63 2004 1114 1117
30. L.W. McPhaul Molecular misreading of the ubiquitin B gene and hepatic mallory body formation Gastroenterology 122 2002 1878 1885
31. S. Song Essential role of E2-25K/Hip-2 in mediating amyloid-beta neurotoxicity Mol. Cell 12 2003 553 563
32. T. Yao, and R.E. Cohen Cyclization of polyubiquitin by the E2-25K ubiquitin conjugating enzyme J. Biol. Chem. 275 2000 36862 36868
33. H. Braak Staging of brain pathology related to sporadic Parkinson's disease Neurobiol. Aging 24 2003 197 211
34. M.R. Cookson The biochemistry of Parkinson's disease Annu. Rev. Biochem. 74 2005 29 52
35. M. Farrer Lewy bodies and parkinsonism in families with parkin mutations Ann. Neurol. 50 2001 293 300
36. Z.K. Wszolek Autosomal dominant parkinsonism associated with variable synuclein and tau pathology Neurology 62 2004 1619 1622
37. M.S. Goldberg Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons J. Biol. Chem. 278 2003 43628 43635
38. M.S. Goldberg Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1 Neuron 45 2005 489 496
39. R. Von Coelln Loss of locus coeruleus neurons and reduced startle in parkin null mice Proc. Natl. Acad. Sci. U. S. A. 101 2004 10744 10749
40. P.C. Wong Genetically engineered mouse models of neurodegenerative diseases Nat. Neurosci. 5 2002 633 639
41. S. Oddo Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction Neuron 39 2003 409 421
42. S. Oddo Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome Neuron 43 2004 321 332
43. F. Fornai Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein Proc. Natl. Acad. Sci. U. S. A. 102 2005 3413 3418
44. A.B. Bowman Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation Hum. Mol. Genet. 14 2005 679 691
45. M. Gaczynska, and P.A. Osmulski Small-molecule inhibitors of proteasome activity Methods Mol. Biol. 301 2005 3 22
46. C.R. Berkers Activity probe for in vivo profiling of the specificity of proteasome inhibitor bortezomib Nat. Methods 2 2005 357 362
47. N.F. Bence Impairment of the ubiquitin-proteasome system by protein aggregation Science 292 2001 1552 1555
48. A. Varshavsky The N-end rule and regulation of apoptosis Nat. Cell Biol. 5 2003 373 376
49. N.P. Dantuma Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells Nat. Biotechnol. 18 2000 538 543
50. K. Lindsten A transgenic mouse model of the ubiquitin/proteasome system Nat. Biotechnol. 21 2003 897 902
51. G.D. Luker Imaging 26S proteasome activity and inhibition in living mice Nat. Med. 9 2003 969 973
52. Y.T. Kwon Female lethality and apoptosis of spermatocytes in mice lacking the UBR2 ubiquitin ligase of the N-end rule pathway Mol. Cell. Biol. 23 2003 8255 8271
53. R. Swanson A conserved ubiquitin ligase of the nuclear envelope/endoplasmic reticulum that functions in both ER-associated and Matalpha2 repressor degradation Genes Dev. 15 2001 2660 2674
54. M.A. Hoyt Ubiquitin-independent mechanisms of mouse ornithine decarboxylase degradation are conserved between mammalian and fungal cells J. Biol. Chem. 278 2003 12135 12143
55. D. Fang, and T.K. Kerppola Ubiquitin-mediated fluorescence complementation reveals that Jun ubiquitinated by Itch/AIP4 is localized to lysosomes Proc. Natl. Acad. Sci. U. S. A. 101 2004 14782 14787
56. D.C. David Proteasomal degradation of tau protein J. Neurochem. 83 2002 176 185
57. F. Fornai Fine structure and biochemical mechanisms underlying nigrostriatal inclusions and cell death after proteasome inhibition J. Neurosci. 23 2003 8955 8966
58. H. Miwa Retrograde dopaminergic neuron degeneration following intrastriatal proteasome inhibition Neurosci. Lett. 380 2005 93 98
59. M. Inden Proteasome inhibitors protect against degeneration of nigral dopaminergic neurons in hemiparkinsonian rats J. Pharmacol. Sci. 97 2005 203 211
60. H. Sawada Proteasome mediates dopaminergic neuronal degeneration, and its inhibition causes alpha-synuclein inclusions J. Biol. Chem. 279 2004 10710 10719
61. K.S. McNaught Proteasome inhibition causes nigral degeneration with inclusion bodies in rats Neuroreport 13 2002 1437 1441
62. K.S. McNaught, and P. Jenner Proteasomal function is impaired in substantia nigra in Parkinson's disease Neurosci. Lett. 297 2001 191 194
63. J.N. Keller Impaired proteasome function in Alzheimer's disease J. Neurochem. 75 2000 436 439
64. L. Regeur No global neocortical nerve cell loss in brains from patients with senile dementia of Alzheimer's type Neurobiol. Aging 15 1994 347 352
65. M.P. Mattson Pathways towards and away from Alzheimer's disease Nature 430 2004 631 639
66. T.M. Dawson, and V.L. Dawson Molecular pathways of neurodegeneration in Parkinson's disease Science 302 2003 819 822
67. Braak, H. et al. (2002) Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages). J. Neurol. 249 (Suppl. 3), III/1-5
68. Paisan-Ruiz, C. et al. LRRK2 gene in Parkinson disease. Neurology (in press)
69. A.B. Singleton alpha-Synuclein locus triplication causes Parkinson's disease Science 302 2003 841